The pharmaceutical giant Novartis will contribute $20-million to build a center for cancer studies at the University of Pennsylvania, where researchers will try to bring new treatments to market, according to
We're sorry. Something went wrong.
We are unable to fully display the content of this page.
The most likely cause of this is a content blocker on your computer or network.
Please allow access to our site, and then refresh this page. You may then be asked to log in, create an account if you don't already have one, or subscribe.
If you continue to experience issues, please contact us at 202-466-1032 or help@chronicle.com